J. Goldman & CO LP Morphic Holding, Inc. Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding MORF
# of Institutions
8Shares Held
4.7MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.53MShares$201 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.06MShares$60.5 Million0.07% of portfolio
-
Ea Series Trust Havertown, PA49.3KShares$2.81 Million0.1% of portfolio
-
Credit Suisse Ag Zurich, V832.2KShares$1.84 Million0.0% of portfolio
-
Deka Bank Deutsche Girozentrale13KShares$740,8700.0% of portfolio
About Morphic Holding, Inc.
- Ticker MORF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,477,100
- Market Cap $2.19B
- Description
- Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...